Why the study?
Does dalteparin prevent postoperative thromboembolism compared to unfractionated heparin in patients undergoing pelvic or abdominal surgery for cancer?
Does dalteparin prevent postoperative thromboembolism compared to unfractionated heparin in patients undergoing pelvic or abdominal surgery for cancer?
A single daily dose of low molecular weight heparin (dalteparin) is as effective as three daily doses of unfractionated heparin for thromboembolism prophylaxis in abdominal oncological surgery, with a better safety profile regarding minor and moderate bleeding.
Answers are grounded in this paper and cite their sources.
Simplifies VTE prophylaxis in cancer surgery with once-daily dosing; confirms LMWH preference over UFH for safety.
Eighty patients undergoing pelvic or abdominal surgery for cancer were randomized in two groups for prevention of postoperative thromboembolism: 40 patients received a 15,000 IU day-1 Calciparine prophylaxis and 40 patients a 5000 anti-Xa U/d Fragmin prophylaxis for 10 days. In the Calciparine group, two patients (5%) developed postoperative pulmonary embolism but none developed it in the Fragmin group. Two patients in the Fragmin group (5%) developed isotopic DVT, which was not confirmed by phlebography. There was no deep vein thrombosis of the lower limbs in the two groups. Important postoperative bleeding (one patient in the Calciparine group and two patients in the Fragmin group) was similar in both groups. Moderate and minor bleeding were significantly lower in the Fragmin group. Haemoglobin and haematocrit changes, total blood loss and transfusion requirements were not different in both groups. It is concluded that, over a 10-day period, one daily 5000 U Fragmin prophylaxis was as effective and safe as three daily 5000 IU Calciparine injections.
No takes yet. Share an insight, caveat, or question.
Jp et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: